Sustainability achievement reflects StageBio’s ongoing commitment to responsible business practices.

Frederick, MD, USA and Freiburg, Germany - 15. July 2026 - StageBio has earned its first-ever sustainability assessment - a Bronze Medal recognition from EcoVadis. The rating places StageBio in the top 35% of all companies assessed by EcoVadis globally and reflects a great achievement by the company's Freiburg, Germany facility.

"Achieving Bronze on our first attempt is a strong comment on the dedication and efforts of our team," said David Bruning, Chief Executive Officer of StageBio. "It reflects the values and practices we already have in place, and it gives us a clear benchmark to build from. Sustainability expectations are rising across our industry, particularly among our European clients, and we intend to keep raising our own standards in the years ahead."

StageBio is a leading provider of GLP-compliant histopathology, image analysis, and specimen archiving services for the biopharmaceutical, medical device, and contract research industries. Our EcoVadis Bronze rating demonstrates that sustainability and responsible business practices are deeply embedded in the way we operate. For our clients, this means partnering with an organization committed to quality, transparency, ethical business conduct, and the continuous advancement of its Environmental, Social, and Governance (ESG) performance.

While we are proud of this achievement, StageBio views this initial EcoVadis rating as a part of the long-term commitment to responsible business practices across our global operations. We will continue to strengthen our sustainability initiatives, enhance our governance practices, and identify new opportunities to reduce our environmental impact while delivering the high-quality scientific services our clients expect.

EcoVadis is one of the world's most widely trusted providers of business sustainability ratings, evaluating companies across four key areas: environmental impact, labor and human rights, ethics, and sustainable procurement.

About StageBio

StageBio is dedicated exclusively to histopathology and comprehensive sample management. As The Histopathology CRO, StageBio partners with pharmaceutical, biotechnology, and medical device sponsors to deliver high-quality GLP and non-GLP pathology support along with secure archiving and biorepository solutions from early discovery through regulatory submission. With operations across the United States and Germany, StageBio combines scientific rigor, operational excellence, and responsive collaboration to keep sponsor programs moving forward with confidence.